Beigene Ltd (BGNE.OQ)
25 Apr 2019
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|50||2010||Executive Chairman of the Board, Chief Executive Officer|
|57||2018||General Manager, China and President|
|55||2015||Chief Financial Officer and Chief Strategy Officer|
|50||2019||Interim Chief Medical Officer, Immuno-Oncology|
|45||2016||Chief Medical Officer, Hematology|
- UPDATE 2-Shanghai Junshi Biosciences soars on HK debut after $394 mln IPO
- UPDATE 1-China's Junshi Biosciences raises $394 mln after pricing IPO at bottom of range -sources
- China's Junshi Biosciences raises $394 mln after pricing IPO at bottom of range -sources
- China biotech Junshi Biosciences seeks up to $414 million in Hong Kong IPO
- China biotech Junshi Biosciences seeks up to $414mln in Hong Kong IPO